Clinical trial
Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport
NCT00168233 is registered in ClinicalTrials.gov with The Alfred as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Impact of HIV Infection and Treatment With Highly Active Antiretroviral Therapy on Reverse Cholesterol Transport
- Lead sponsor
- The Alfred
- Phase
- Observational
- Overall status
- Completed
- Start date
- June 30, 2005
- Completion date
- March 31, 2011
- Enrollment
- 44 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.